Phibro Animal Health (PAHC) to Release Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) will issue its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.29 per share for the quarter. Phibro Animal Health has set its FY 2024 guidance at 1.040-1.160 EPS.Parties interested in participating in the company's conference call can do so using this link.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.06. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. The firm had revenue of $249.90 million during the quarter, compared to analyst estimates of $242.91 million. On average, analysts expect Phibro Animal Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Phibro Animal Health Trading Down 2.1 %

Shares of PAHC stock traded down $0.35 on Wednesday, reaching $16.35. 228,382 shares of the company's stock were exchanged, compared to its average volume of 152,929. The company's fifty day simple moving average is $13.02 and its 200 day simple moving average is $11.83. The stock has a market capitalization of $662.18 million, a PE ratio of 46.39, a P/E/G ratio of 6.19 and a beta of 0.75. Phibro Animal Health has a 52 week low of $9.40 and a 52 week high of $17.10. The company has a current ratio of 3.12, a quick ratio of 1.60 and a debt-to-equity ratio of 1.66.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 6th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.94%. Phibro Animal Health's payout ratio is currently 133.33%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Tuesday, April 9th.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.